Search research articles
Contact Us
Filters
Showing results (111-120 of 143) with videos related to
Page
of 15
Sort By:
Clinical Nuclear Medicine
|
January 25, 2021
Optimal Time for 124I PET/CT Imaging in Metastatic Differentiated Thyroid Cancer
Di Wu, Donika Plyku, Kanchan Kulkarni, et al.
Thyroid : Official Journal of the American Thyroid Association
|
April 25, 2019
Improved Survival After Multimodal Approach with <sup>131</sup>I Treatment in Patients with Bone Metastases Secondary to Differentiated Thyroid Cancer
Di Wu, Cristiane J Gomes Lima, Shari L Moreau, et al.
Endocrine Connections
|
August 10, 2017
Amifostine does not protect thyroid cancer cells in DNA damaging <i>in vitro</i> models
Joanna Klubo-Gwiezdzinska, John Costello, Kirk Jensen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 7, 2005
KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity
Nikolaos Stathatos, Isabelle Bourdeau, Allan V Espinosa, et al.
The Journal of Endocrinology
|
May 31, 2012
The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stress
Joanna Klubo-Gwiezdzinska, Kirk Jensen, Andrew Bauer, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 5, 2002
Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction
Victor J Bernet, Jeffrey Anderson, Yashesh Vaishnav, et al.
American Journal of Surgery
|
October 3, 2021
Comparing the rate and extent of malignancy in surgically excised thyroid nodules across race and ethnicity
Hui Zheng, Victoria Lai, Jana Lu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 8, 2024
Association of Free Thyroxine With Progression-Free Survival in Intermediate and High-Risk Differentiated Thyroid Cancer
Raisa Ghosh, Sungyoung Auh, Sriram Gubbi, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 27, 2023
Efficacy of Levothyroxine Sodium Soft Gelatin Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors: An Open-Label Study
Issac Sachmechi, Kathryn Jean Lucas, Larry D Stonesifer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 9, 2012
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET
Douglas Van Nostrand, Gauri R Khorjekar, Jeff O'Neil, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 143) with videos related to
Sort By:
Page
of 15
Clinical Nuclear Medicine
|
January 25, 2021
Optimal Time for 124I PET/CT Imaging in Metastatic Differentiated Thyroid Cancer
Di Wu, Donika Plyku, Kanchan Kulkarni, et al.
Thyroid : Official Journal of the American Thyroid Association
|
April 25, 2019
Improved Survival After Multimodal Approach with <sup>131</sup>I Treatment in Patients with Bone Metastases Secondary to Differentiated Thyroid Cancer
Di Wu, Cristiane J Gomes Lima, Shari L Moreau, et al.
Endocrine Connections
|
August 10, 2017
Amifostine does not protect thyroid cancer cells in DNA damaging <i>in vitro</i> models
Joanna Klubo-Gwiezdzinska, John Costello, Kirk Jensen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 7, 2005
KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity
Nikolaos Stathatos, Isabelle Bourdeau, Allan V Espinosa, et al.
The Journal of Endocrinology
|
May 31, 2012
The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stress
Joanna Klubo-Gwiezdzinska, Kirk Jensen, Andrew Bauer, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 5, 2002
Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction
Victor J Bernet, Jeffrey Anderson, Yashesh Vaishnav, et al.
American Journal of Surgery
|
October 3, 2021
Comparing the rate and extent of malignancy in surgically excised thyroid nodules across race and ethnicity
Hui Zheng, Victoria Lai, Jana Lu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 8, 2024
Association of Free Thyroxine With Progression-Free Survival in Intermediate and High-Risk Differentiated Thyroid Cancer
Raisa Ghosh, Sungyoung Auh, Sriram Gubbi, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 27, 2023
Efficacy of Levothyroxine Sodium Soft Gelatin Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors: An Open-Label Study
Issac Sachmechi, Kathryn Jean Lucas, Larry D Stonesifer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 9, 2012
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET
Douglas Van Nostrand, Gauri R Khorjekar, Jeff O'Neil, et al.
Page
of 15